These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Ezzati M; Oza S; Danaei G; Murray CJ Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146 [TBL] [Abstract][Full Text] [Related]
43. Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study. Rodriguez CJ; Swett K; Agarwal SK; Folsom AR; Fox ER; Loehr LR; Ni H; Rosamond WD; Chang PP JAMA Intern Med; 2014 Aug; 174(8):1252-61. PubMed ID: 24935209 [TBL] [Abstract][Full Text] [Related]
44. Cardiovascular Events and Costs With Home Blood Pressure Telemonitoring and Pharmacist Management for Uncontrolled Hypertension. Margolis KL; Dehmer SP; Sperl-Hillen J; O'Connor PJ; Asche SE; Bergdall AR; Green BB; Nyboer RA; Pawloski PA; Trower NK; Maciosek MV Hypertension; 2020 Oct; 76(4):1097-1103. PubMed ID: 32862713 [TBL] [Abstract][Full Text] [Related]
45. Association of social relationships with incident cardiovascular events and all-cause mortality. Gronewold J; Kropp R; Lehmann N; Schmidt B; Weyers S; Siegrist J; Dragano N; Jöckel KH; Erbel R; Hermann DM; Heart; 2020 Sep; 106(17):1317-1323. PubMed ID: 32165451 [TBL] [Abstract][Full Text] [Related]
46. Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction. Ohm J; Kuja-Halkola R; Warnqvist A; Häbel H; Skoglund PH; Sundström J; Hambraeus K; Jernberg T; Svensson P Circulation; 2023 Jul; 148(3):256-267. PubMed ID: 37459408 [TBL] [Abstract][Full Text] [Related]
47. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. Xu W; Goldberg SI; Shubina M; Turchin A BMJ; 2015 Feb; 350():h158. PubMed ID: 25655523 [TBL] [Abstract][Full Text] [Related]
48. Adult height and risk of death from all-cause, cardiovascular, and cancer-specific disease: The Rural Chinese Cohort Study. Zhao Y; Zhang M; Liu Y; Sun H; Sun X; Yin Z; Li H; Ren Y; Liu D; Liu F; Chen X; Liu L; Cheng C; Zhou Q; Hu D Nutr Metab Cardiovasc Dis; 2019 Dec; 29(12):1299-1307. PubMed ID: 31640891 [TBL] [Abstract][Full Text] [Related]
49. Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China. Lu Q; Zhang Y; Geng T; Yang K; Guo K; Min X; He M; Guo H; Zhang X; Yang H; Wu T; Pan A; Liu G JAMA Netw Open; 2022 Feb; 5(2):e2146118. PubMed ID: 35103793 [TBL] [Abstract][Full Text] [Related]
50. Explaining significant differences in subjective and objective measures of cardiovascular health: evidence for the socioeconomic gradient in a population-based study. Mosca I; Bhuachalla BN; Kenny RA BMC Cardiovasc Disord; 2013 Aug; 13():64. PubMed ID: 24119371 [TBL] [Abstract][Full Text] [Related]
51. Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study. Ohkuma T; Woodward M; Jun M; Muntner P; Hata J; Colagiuri S; Harrap S; Mancia G; Poulter N; Williams B; Rothwell P; Chalmers J; Hypertension; 2017 Aug; 70(2):461-468. PubMed ID: 28584014 [TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of left ventricular mass change during treatment of hypertension. Devereux RB; Wachtell K; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris K; Aurup P; Dahlöf B JAMA; 2004 Nov; 292(19):2350-6. PubMed ID: 15547162 [TBL] [Abstract][Full Text] [Related]
54. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A; J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861 [TBL] [Abstract][Full Text] [Related]
55. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States. Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046 [TBL] [Abstract][Full Text] [Related]
56. Inequality in Mortality and Cardiovascular Risk Among Young, Low-Income, Self-Employed Workers: Nationwide Retrospective Cohort Study. Yun B; Park H; Choi J; Oh J; Sim J; Kim Y; Lee J; Yoon JH JMIR Public Health Surveill; 2024 Sep; 10():e48047. PubMed ID: 39302342 [TBL] [Abstract][Full Text] [Related]
57. Optimal Blood Pressure in Elderly Hypertensive Subjects: A Korean National Health Insurance Service Health Examinee Cohort Study. Seo J; Lee CJ; Hwang J; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S Am J Hypertens; 2018 Aug; 31(9):1033-1041. PubMed ID: 29767674 [TBL] [Abstract][Full Text] [Related]
58. Association Between Protein Intake and Mortality in Hypertensive Patients Without Chronic Kidney Disease in the OLD-HTA Cohort. Courand PY; Lesiuk C; Milon H; Defforges A; Fouque D; Harbaoui B; Lantelme P Hypertension; 2016 Jun; 67(6):1142-9. PubMed ID: 27091898 [TBL] [Abstract][Full Text] [Related]
59. Association of Hypertension and Blood Pressure With Kidney Cancer Risk: A Nationwide Population-Based Cohort Study. Kim CS; Han KD; Choi HS; Bae EH; Ma SK; Kim SW Hypertension; 2020 Jun; 75(6):1439-1446. PubMed ID: 32336229 [TBL] [Abstract][Full Text] [Related]
60. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial. Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]